These differences are not considered to be clinically meaningful
Whats the Big Deal with GLP-1 Drugs
Patent terms, supplementary protection certificates (the European equivalent of patent term extensions), regulatory exclusivity periods, and the timing of initial product approvals all vary by country
It was approved by the FDA as a prescription medication for people with lipodystrophy
It is meant to be used alongside a reduced-calorie diet and increased physical activity, not as a standalone fix
Potential direct benefits suggested by preclinical research include reduction of neuroinflammation, enhancement of neuronal insulin signaling, promotion of synaptic plasticity, and possible reduction in pathological protein accumulation